Helena Pozios

Helena Pozios serves as Chief Of Investment for Biotechnology & MedTech companies, start-up and investment fund opportunities at Sambrinvest. She is also Board Member in a few biotech funds and companies such as Eso Biotech, ConveyXo, Apaxen, Spentys and funds such as Theodorus, Innovation Fund, Newton and Fund+. Before joining SambrInvest, Ms. Pozios worked for 8 years at HSBC France as Associate Director in the “Leveraged and Acquisition Finance” team (Mid Cap/Large companies with an enterprise value ranging from €100M to €1bn) and as Analyst in Venture Capital in CDC Capital Investment. Ms. Pozios brings expertise in financial analysis, financing, scientific analysis, pitching & market presentation, and acquisition due diligence.

In addition to these activities, Ms. Pozios launched Bouche B in 2015, a new brand specialized in organic chocolate free from gluten and soy. Ms. Pozios has an engineering degree in biotechnology and chemistry from ESIEE in Paris, as well as a Master’s degree in Finance from ESSEC Business School, Paris.

‍